Standard Glass Lining Technology IPO Subscription Status: The initial public offering (IPO) of Standard Glass Lining Technology Ltd received 180 times subscription so far on the last day bidding process (January 8). The IPO received bids for 3,75,25,66,505 shares against an offer of 2,08,29,567 shares, according to the BSE data.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

As the last count (3:33 pm), the non-institutional investor (NII) category witnessed a subscription of 265.07 times, while the retail individual investor (RII) portion fetched 60.47 times. The portion for qualified institutional buyers (QIBs) saw 331.60 times the subscription.

ALSO READ | Standard Glass IPO Review: Should you subscribe? Know what Anil Singhvi suggests

The Standard Glass Lining Technology stock is likely to debut on the exchanges BSE and NSE on Monday, January 13, 2025.

Standard Glass Lining Technology IPO Key Details

  • Selling shareholders via OFS: S2 Engineering Services, Kandula Ramakrishna, Kandula Krishna Veni, Nageswara Rao Kandula, Standard Holdings, Katragadda Venkata Ramani, and Venkata Siva Prasad Katragadda
  • Book-running Lead Managers (BRLMs): IIFL Capital Services Ltd and Motilal Oswal Investment Advisors Ltd
  • Registrar: KFin Technologies

ALSO READ | Quadrant Future Tek IPO Day 2: Issue subscribed over 29 times so far; RII, HNI portions fully booked

What does Standard Glass Lining Technology do?

Standard Glass Lining Technology Ltd specializes in providing turnkey solutions for pharmaceutical and chemical manufacturers, encompassing design, engineering, manufacturing, assembly, installation, and commissioning. Its clients include leading pharmaceutical companies like Aurobindo Pharma, Cadila Pharmaceuticals, Granules India Ltd, Macleods Pharmaceuticals, Piramal Pharma, and Suven Pharmaceuticals.